Elevance Health Inc. (ELV)

US — Healthcare Sector
Peers: CI  REGN  COR  ZTS  HUM  IDXX  CVS  GSK  BDX  GEHC 

Automate Your Wheel Strategy on ELV

With Tiblio's Option Bot, you can configure your own wheel strategy including ELV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ELV
  • Rev/Share 862.7989
  • Book/Share 195.2259
  • PB 1.7391
  • Debt/Equity 0.0211
  • CurrentRatio 1.5602
  • ROIC 0.0701

 

  • MktCap 75232266051.0
  • FreeCF/Share 16.6829
  • PFCF 19.9714
  • PE 13.8149
  • Debt/Assets 0.0076
  • DivYield 0.02
  • ROE 0.1291

 

  • Rating A
  • Score 4
  • Recommendation Buy
  • P/E Score 2
  • DCF Score 5
  • P/B Score 3
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation ELV Goldman -- Neutral -- -- Oct. 14, 2025
Downgrade ELV Argus Buy Hold -- -- July 21, 2025
Downgrade ELV Leerink Partners Outperform Market Perform -- $310 July 18, 2025
Downgrade ELV Robert W. Baird Outperform Neutral -- $529 April 15, 2025
Upgrade ELV Argus Hold Buy -- $450 March 17, 2025
Downgrade ELV Stephens Overweight Equal Weight $520 $440 Jan. 22, 2025
Downgrade ELV Argus Buy Hold -- -- Oct. 18, 2024

News

U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
CI, CNC, ELV, HUM, UNH
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Negative

US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact …

Read More
image for news U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
ELV, INTU, MSCI
Published: February 23, 2025 by: Seeking Alpha
Sentiment: Positive

Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.

Read More
image for news Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)

About Elevance Health Inc. (ELV)

  • IPO Date 2001-10-30
  • Website https://www.elevancehealth.com
  • Industry Medical - Healthcare Plans
  • CEO Gail Koziara Boudreaux
  • Employees 104200

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.